91 related articles for article (PubMed ID: 28645931)
1. A potential role of the unfolded protein response in post-transplant cancer.
Bodeau S; Sauzay C; Pluquet O; Choukroun G; Galmiche A
Clin Sci (Lond); 2017 Jul; 131(13):1429-1436. PubMed ID: 28645931
[TBL] [Abstract][Full Text] [Related]
2. Immunosuppressive calcineurin inhibitor cyclosporine A induces proapoptotic endoplasmic reticulum stress in renal tubular cells.
Yilmaz DE; Kirschner K; Demirci H; Himmerkus N; Bachmann S; Mutig K
J Biol Chem; 2022 Mar; 298(3):101589. PubMed ID: 35033536
[TBL] [Abstract][Full Text] [Related]
3. Targeting the Unfolded Protein Response as a Potential Therapeutic Strategy in Renal Carcinoma Cells Exposed to Cyclosporine A.
Bodeau S; Sauzay C; Nyga R; Louandre C; Descamps V; François C; Godin C; Choukroun G; Galmiche A
Anticancer Res; 2017 Mar; 37(3):1049-1057. PubMed ID: 28314264
[TBL] [Abstract][Full Text] [Related]
4. Molecular basis of posttransplant squamous cell carcinoma: the potential role of cyclosporine a in carcinogenesis.
Tiu J; Li H; Rassekh C; van der Sloot P; Kovach R; Zhang P
Laryngoscope; 2006 May; 116(5):762-9. PubMed ID: 16652084
[TBL] [Abstract][Full Text] [Related]
5. Suppression of NF-kappaB by cyclosporin a and tacrolimus (FK506) via induction of the C/EBP family: implication for unfolded protein response.
Du S; Hiramatsu N; Hayakawa K; Kasai A; Okamura M; Huang T; Yao J; Takeda M; Araki I; Sawada N; Paton AW; Paton JC; Kitamura M
J Immunol; 2009 Jun; 182(11):7201-11. PubMed ID: 19454717
[TBL] [Abstract][Full Text] [Related]
6. Treatment strategies in pediatric solid organ transplant recipients with calcineurin inhibitor-induced nephrotoxicity.
Tönshoff B; Höcker B
Pediatr Transplant; 2006 Sep; 10(6):721-9. PubMed ID: 16911497
[TBL] [Abstract][Full Text] [Related]
7. Role of the unfolded protein response in tumor cell characteristics and cancer outcome.
Galmiche A; Sauzay C; Chevet E; Pluquet O
Curr Opin Oncol; 2017 Jan; 29(1):41-47. PubMed ID: 27845970
[TBL] [Abstract][Full Text] [Related]
8. Deregulation of XPC and CypA by cyclosporin A: an immunosuppression-independent mechanism of skin carcinogenesis.
Han W; Soltani K; Ming M; He YY
Cancer Prev Res (Phila); 2012 Sep; 5(9):1155-62. PubMed ID: 22846842
[TBL] [Abstract][Full Text] [Related]
9. The unfolded protein response as a target for cancer therapy.
Nagelkerke A; Bussink J; Sweep FC; Span PN
Biochim Biophys Acta; 2014 Dec; 1846(2):277-84. PubMed ID: 25069067
[TBL] [Abstract][Full Text] [Related]
10. Combination of N-(3'4'-dimethoxycinnamoyl) anthranilic acid with cyclosporin A treatment preserves immunosuppressive effect and reduces the side effect of cyclosporin A in rat.
Yong-Gang X; Ming-Zhe W; Jin-Yan Z; Zhi-Hai P; Jun-Ming X
Eur J Pharmacol; 2014 Apr; 728():16-23. PubMed ID: 24530417
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
Krämer BK; Montagnino G; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Krüger B; Ortuño J; Köhler H; Kunzendorf U; Stummvoll HK; Tabernero JM; Mühlbacher F; Rivero M; Arias M;
Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
[TBL] [Abstract][Full Text] [Related]
12. Cyclosporin A, but not everolimus, inhibits DNA repair mediated by calcineurin: implications for tumorigenesis under immunosuppression.
Thoms KM; Kuschal C; Oetjen E; Mori T; Kobayashi N; Laspe P; Boeckmann L; Schön MP; Emmert S
Exp Dermatol; 2011 Mar; 20(3):232-6. PubMed ID: 21323745
[TBL] [Abstract][Full Text] [Related]
13. Calcineurin inhibitors recruit protein kinases JAK2 and JNK, TLR signaling and the UPR to activate NF-κB-mediated inflammatory responses in kidney tubular cells.
González-Guerrero C; Ocaña-Salceda C; Berzal S; Carrasco S; Fernández-Fernández B; Cannata-Ortiz P; Egido J; Ortiz A; Ramos AM
Toxicol Appl Pharmacol; 2013 Nov; 272(3):825-41. PubMed ID: 23958496
[TBL] [Abstract][Full Text] [Related]
14. Expression of multidrug resistance P-glycoprotein in kidney allografts from cyclosporine A-treated patients.
Koziolek MJ; Riess R; Geiger H; Thévenod F; Hauser IA
Kidney Int; 2001 Jul; 60(1):156-66. PubMed ID: 11422747
[TBL] [Abstract][Full Text] [Related]
15. Clinical insights for cancer outcomes in renal transplant patients.
Alberú J
Transplant Proc; 2010 Nov; 42(9 Suppl):S36-40. PubMed ID: 21095450
[TBL] [Abstract][Full Text] [Related]
16. Clinical relevance of post-transplant pharmacodynamic analysis of cyclosporine in renal transplantation.
Kurata Y; Kuzuya T; Miwa Y; Iwasaki K; Haneda M; Amioka K; Yamada K; Watarai Y; Katayama A; Uchida K; Kobayashi T
Int Immunopharmacol; 2014 Oct; 22(2):384-91. PubMed ID: 25073119
[TBL] [Abstract][Full Text] [Related]
17. Targeting the unfolded protein response for disease intervention.
Rivas A; Vidal RL; Hetz C
Expert Opin Ther Targets; 2015; 19(9):1203-18. PubMed ID: 26166159
[TBL] [Abstract][Full Text] [Related]
18. Exposure to tributyltin induces endoplasmic reticulum stress and the unfolded protein response in zebrafish.
Komoike Y; Matsuoka M
Aquat Toxicol; 2013 Oct; 142-143():221-9. PubMed ID: 24055755
[TBL] [Abstract][Full Text] [Related]
19. One thousand renal transplants at Belfast City Hospital: post-graft neoplasia 1968-1999, comparing azathioprine only with cyclosporin-based regimes in a single centre.
McGeown MG; Douglas JF; Middleton D
Clin Transpl; 2000; ():193-202. PubMed ID: 11512313
[TBL] [Abstract][Full Text] [Related]
20. Regulating extracellular proteostasis capacity through the unfolded protein response.
Genereux JC; Wiseman RL
Prion; 2015; 9(1):10-21. PubMed ID: 25946012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
